These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36799979)

  • 1. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
    Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
    Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
    Cheng F; Wen Z; Feng X; Wang X; Chen Y
    Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple Negative Breast Cancer Detection Using LC-MS/MS Lipidomic Profiling.
    Eghlimi R; Shi X; Hrovat J; Xi B; Gu H
    J Proteome Res; 2020 Jun; 19(6):2367-2378. PubMed ID: 32397718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia.
    Yan X; Zhao W; Wei J; Yao Y; Sun G; Wang L; Zhang W; Chen S; Zhou W; Zhao H; Li X; Xiao Y; Li Y
    Int J Cancer; 2022 May; 150(9):1549-1559. PubMed ID: 35076938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
    Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
    J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new methodology to reveal potential nucleic acid modifications associated with the risk of endometrial cancer through dispersive solid-phase extraction coupled with UHPLC-QE-Orbitrap-MS/MS and HPLC-UV.
    Zhao H; Zhang X; Zuo L; Li L; Yang H; Zhang M; Wang N; Jia Q; Liu Y
    Anal Bioanal Chem; 2024 Apr; 416(10):2439-2452. PubMed ID: 38400939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer.
    Chen Y; Ma Z; Shen X; Li L; Zhong J; Min LS; Xu L; Li H; Zhang J; Dai L
    Biomed Res Int; 2018; 2018():5276240. PubMed ID: 30175133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
    Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
    Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.
    Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
    PeerJ; 2023; 11():e16424. PubMed ID: 38077439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma lipidome of the Quaker parrot (Myiopsitta monachus).
    Beaufrère H; Gardhouse SM; Wood RD; Stark KD
    PLoS One; 2020; 15(12):e0240449. PubMed ID: 33259543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
    Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
    J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
    Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
    Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometry.
    Chen J; Liu J; Cao D
    BMC Womens Health; 2023 Nov; 23(1):583. PubMed ID: 37940929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
    Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
    Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature.
    Ecker J; Benedetti E; Kindt ASD; Höring M; Perl M; Machmüller AC; Sichler A; Plagge J; Wang Y; Zeissig S; Shevchenko A; Burkhardt R; Krumsiek J; Liebisch G; Janssen KP
    Gastroenterology; 2021 Sep; 161(3):910-923.e19. PubMed ID: 34000281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic prediction of endometrial cancer.
    Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
    Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential serum markers for endometrial cancer using protein expression profiling.
    Takano M; Kikuchi Y; Asakawa T; Goto T; Kita T; Kudoh K; Kigawa J; Sakuragi N; Sakamoto M; Sugiyama T; Yaegashi N; Tsuda H; Seto H; Shiwa M
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):475-81. PubMed ID: 19756734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
    Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F
    J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
    Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
    BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.